Results 151 to 160 of about 15,674 (165)

Neuroendocrine differentiation of prostatic adenocarcinoma – an important cause for castration-resistant disease recurrence

Journal of Laboratory Medicine, 2019
João Lobo
exaly  

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

Journal of Urology, 2018
William T Lowrance, William K Oh, David F Jarrard   +2 more
exaly  

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015

Journal of Urology, 2016
William T Lowrance, Michael S Cookson
exaly  

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

Annals of Oncology, 2013
S North, Rhonda L Bitting, K N Chi
exaly  

The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells

Journal of Urology, 2015
Peter E Lonergan, Liguo Wang, Lucy J Schmidt   +2 more
exaly  

Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate

Journal of Urology, 2020
Arñas Bakavicius, Tapio Visakorpi, Daniel C Danila   +2 more
exaly  

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer

Journal of Urology, 2017
Laurence Klotz, Vasundara Venkateswaran   +1 more
exaly  

Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer

Journal of Urology, 2018
Jongsoo Lee, Hye Sun Lee, Jee Soo Ha
exaly  

Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo

Journal of Urology, 2017
Mary-Ellen Taplin, Andrew J Armstrong, De Phung   +2 more
exaly  

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

Therapeutic Advances in Medical Oncology, 2016
Elena Verzoni, Paolo Grassi, Raffaele Ratta   +2 more
exaly